BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36995340)

  • 1. Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages.
    Gonzalez MA; Lu DR; Yousefi M; Kroll A; Lo CH; Briseño CG; Watson JEV; Novitskiy S; Arias V; Zhou H; Plata Stapper A; Tsai MK; Ashkin EL; Murray CW; Li CM; Winslow MM; Tarbell KV
    J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36995340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages are metabolically heterogeneous within the tumor microenvironment.
    Geeraerts X; Fernández-Garcia J; Hartmann FJ; de Goede KE; Martens L; Elkrim Y; Debraekeleer A; Stijlemans B; Vandekeere A; Rinaldi G; De Rycke R; Planque M; Broekaert D; Meinster E; Clappaert E; Bardet P; Murgaski A; Gysemans C; Nana FA; Saeys Y; Bendall SC; Laoui D; Van den Bossche J; Fendt SM; Van Ginderachter JA
    Cell Rep; 2021 Dec; 37(13):110171. PubMed ID: 34965415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review.
    Lecoultre M; Dutoit V; Walker PR
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization.
    Finkernagel F; Reinartz S; Lieber S; Adhikary T; Wortmann A; Hoffmann N; Bieringer T; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
    Oncotarget; 2016 Nov; 7(46):75339-75352. PubMed ID: 27659538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
    Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
    Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
    Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
    Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.
    Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J
    Front Immunol; 2021; 12():756722. PubMed ID: 34804043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages.
    Hoppstädter J; Dembek A; Höring M; Schymik HS; Dahlem C; Sultan A; Wirth N; Al-Fityan S; Diesel B; Gasparoni G; Walter J; Helms V; Huwer H; Simon M; Liebisch G; Schulz MH; Kiemer AK
    EBioMedicine; 2021 Oct; 72():103578. PubMed ID: 34571364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
    Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
    Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
    Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
    Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting macrophages: a novel treatment strategy in solid tumors.
    Liu M; Liu L; Song Y; Li W; Xu L
    J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer.
    Lu J; Li J; Lin Z; Li H; Lou L; Ding W; Ouyang S; Wu Y; Wen Y; Chen X; Yue P; Wang Y; Liu P; Lu J; Zhang J; Feng W; Zhang X
    Cancer Lett; 2023 Jun; 564():216205. PubMed ID: 37146936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.
    Ma D; Zhan D; Fu Y; Wei S; Lal B; Wang J; Li Y; Lopez-Bertoni H; Yalcin F; Dzaye O; Eberhart CG; Laterra J; Wilson MA; Ying M; Xia S
    Cancer Lett; 2021 Oct; 517():35-45. PubMed ID: 34098063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CCR2
    Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
    Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
    Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.
    Kim SH; Kim SJ; Park J; Joe Y; Lee SE; Saeidi S; Zhong X; Kim SH; Park SA; Na HK; Chung HT; Surh YJ
    Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33809707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.